Search

The present work investigated the differences in the composition and internal microstructure of four types gypsum rock—fiber gypsum, transparent gypsum, alabaster, and ordinary gypsum by X-ray fluorescence spectrometry, X-ray diffraction, scanning electron microscope and Brazilian split test, and analyzed its effects on the tensile strength and fracture characteristics of gypsum rock. For alabaster, fiber gypsum, transparent gypsum, and ordinary gypsum, CaSO4·2H2O is the main component with 72.78%, 72.72%, 72.57%, and 71.51% content, and tensile strength of 1.79, 2.22, 3.22, and 4.35 MPa, respectively. In addition, the fracture line is arc-shaped, vertical, and zigzag for fiber gypsum, ordinary and transparent gypsums, and alabaster, respectively. On the microscopic level, fiber gypsum has an evident striated structure while the gradual increased pore development for alabaster, transparent gypsum, and ordinary gypsum. Gypsum rock has an obvious layered crystal structure with the increase of CaSO4·2H2O, contributing to the phenomenon with a larger grain size and lower tensile strength. In addition, the number of particles for alabaster, transparent gypsum, and ordinary gypsum increased in turn, while their particle size decreased uniformly, indicating that the lower CaSO4·2H2O content, the more sufficient energy accumulation and release. This paper can provide a theoretical basis for the analysis of the mechanical properties of rocks with different mineral composition and contribute to the design for different ore grades mining.

Although we have found that protease-treated royal jelly (pRJ) benefit for the skeletal muscle mass and strength in the aged animals, the potential beneficial effects have not been evaluated in humans. The aim of this study was to determine whether pRJ intake had beneficial effects on muscle strength in elderly nursing home residents. One hundred and ninety-four subjects enrolled into this multicenter, randomized, double-blind, placebo-controlled study. Subjects received either placebo(Group 1), pRJ 1.2 g/d(Group 2), or 4.8 g/d(Group 3). Data through 1 year are reported for 163 subjects. The primary outcome measure is handgrip strength. Secondary outcomes include several physical performance tests (six-minute walk test, timed up and go test, and standing on one leg with eyes closed). The dropout rate was 16.0%. The means (95% confidence interval) of change in handgrip strength for placebo, low-dose, and high-dose groups are −0.98(−2.04,0.08), 0.50(−0.65,1.65) and 1.03(−0.37,2.44) kg (P = 0.06, P for trend = 0.02), respectively. No significant effects of the interventions were observed for physical performances. These findings suggest that pRJ treatment might not improve, but rather attenuate the progression of decrease in muscle strength in elderly people. In addition, we have not found that pRJ intervention can achieve improvement or attenuating the decrease in physical performance.